IARC shared on LinkedIn:
“New IARC paper with partners from Seoul National University College of Medicine finds higher circulating levels of bilirubin inversely associated with risk of Colorectal Cancer.
Results support possible use of bilirubin as biomarker for Colorectal Cancer risk assessment.”
Read further.
Source: IARC/LinkedIn